Skip to main content
. 2022 Jun 8;2022:9840678. doi: 10.34133/2022/9840678

Table 3.

Experimental groups of study. SC = subconjunctival, EOS = end of study, D0 = day 0, D3 = day 3, D7 = day 7.

ID Treatment N VEGF Avastin MIFU EOS
Control VEGF (3 μg) 3 D0 NA NA D7
Control 1 VEGF (3 μg) + Avastin (1.25 mg) IVT 3 D0 D3 NA D7
Control 2 VEGF (3 μg) + Avastin (1.25 mg) SC 3 D0 D3 NA D7
Treatment VEGF(3 μg) + MIFU(3 min) + Avastin(1.25 mg) SC 3 D0 D3 D3 D7